RE
AMPE

RBC Europe’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

RBC Europe’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-38
Closed -$6.37K – 1100
2019
Q1 		$6.37K Hold
38
– – ﹤0.01% 898
2018
Q4 		$4.47K Hold
38
– – ﹤0.01% 931
2018
Q3 		$5.76K Hold
38
– – ﹤0.01% 945
2018
Q2 		$24.9K Buy
+38
New +$28.4K ﹤0.01% 628

Other funds holding AMPE

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

RBC Europe's AMPE Position: Q2 2019 in Review

RBC Europe sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2019, closing a stake of 38 shares — an estimated $6.37K sold.

RBC Europe first reported a position in AMPE in Q2 2018 and held it in 4 quarters. The position peaked at $24.9K in Q2 2018. 81 funds tracked by Wall St. Rank hold AMPE as of Q2 2019.

  • RBC Europe reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
  • RBC Europe sold 38 Ampio Pharmaceuticals Inc. shares in Q2 2019, an estimated $6.37K.
  • RBC Europe first reported a position in Ampio Pharmaceuticals Inc. in Q2 2018 and held it in 4 quarters.
  • RBC Europe's Ampio Pharmaceuticals Inc. position peaked at $24.9K in Q2 2018.
  • 81 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2019.

Based on RBC Europe's 13F filing for Q2 2019, filed 9 Nov 2023.